Pulse Explore Journal Club Debates Trending Researchers

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Home Explore Journal Club Trending

⌘+K

Umbilical cord-derived Wharton’s jelly for regenerative medicine applications | Synapse

February 13, 2020Open Access

Umbilical cord-derived Wharton’s jelly for regenerative medicine applications

Key Points

Key points are not available for this paper at this time.

Abstract

There are numerous growth factors, cytokines, hyaluronic acid, and extracellular vesicles present in the Wharton's jelly formulation analyzed. The amount of these factors in Wharton's jelly is higher compared with other biologics and may play a role in reducing inflammation and pain and augment healing of musculoskeletal injuries.

Ask AI

Helpful

Bookmark

Share

View Full Paper

Ask AI

Helpful

Bookmark

Share

View Full Paper

Cite This Study

Gupta et al. (Thu,) studied this question.

synapsesocial.com/papers/69da9a8685037e71b26842b6 https://doi.org/https://doi.org/10.1186/s13018-020-1553-7

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Therapeutic Modulation of Growth Factors and Cytokines in Regenerative Medicine2006 · 43 citations
2Sequential delivery of immunomodulatory cytokines to facilitate the M1-to-M2 transition of macrophages and enhance vascularization of bone scaffolds2014 · 778 citations
3Interleukin-1 mediates the behavioral hyperalgesia produced by lithium chloride and endotoxin1993 · 213 citations
4Comparison of two different molecular weight intra-articular injections of hyaluronic acid for the treatment of knee osteoarthritis.2016 · 37 citations
5Platelet-rich plasma preparation for regenerative medicine: optimization and quantification of cytokines and growth factors2013 · 715 citations